Schedule your consultation today and take the next step toward a healthier, more confident you
While preliminary safety data appears promising, more comprehensive human studies are needed to establish definitive dosing guidelines and safety parameters
Who It Is For Athletes recovering from tendon, ligament, or muscle injuries Post-surgical patients seeking accelerated healing (with physician approval) Patients with chronic joint pain, tendinopathy, or repetitive strain injuries Individuals with gut health issues BPC-157 specifically supports intestinal mucosal healing Active adults who want to reduce recovery time between training sessions Patients with chronic inflammatory conditions seeking systemic inflammation reduction What to Expect Week 1-2: Reduction in acute pain and inflammation at injury sites
Dont wait to investigate
Its original development focused on neurodegenerative conditions like Parkinsons and Alzheimers, and while promising fat loss data emerged, it has yet to receive regulatory approval for commercial use
Identification of a putative lysosomal cobalamin exporter altered in the cblF defect of vitamin B12 metabolism
